⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of China Isotope & Radiation Corporation (CIRC) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
China Isotope & Radiation Corporation (CIRC) is a holding subsidiary of the China National Nuclear Corporation (CNNC) and the largest nuclear enterprise in China specializing in the R&D, manufacturing, distribution, and service of nuclear-related products. The company operates across the entire value chain of nuclear technology applications, including radiopharmaceuticals, radioactive sources, radiation engineering, and nuclear medicine equipment.
CIRC maintains a dominant market position in China, particularly in diagnostic and therapeutic radiopharmaceuticals, where it holds a significant market share. With over 50 production lines and a nationwide network of radiopharmacies, the company provides comprehensive nuclear medicine solutions and has expanded its footprint internationally by exporting products and services to over 50 countries.
CLASSIFICATION
SIZE & FINANCIALS
Ownership:subsidiary
Status:operating
STOCK
Exchange:HKEX
Ticker:1763
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Radiopharmaceuticals, Radioactive Sources
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:China National Nuclear Corporation (CNNC)
Subsidiaries:Chengdu Gaotong Isotope Co., Ltd. (CNGT), HTA Co., Ltd.
Key Partnerships:International Atomic Energy Agency (IAEA) - Collaboration on nuclear science and quality management
COMPETITION
Position:Leader
LINKS
Website:circ.com.cn
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with China Isotope & Radiation Corporation (CIRC). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.